Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders
Jeffrey L. Seeburger(Merck & Co., Inc., Rahway, NJ, USA (United States)), Kathryn M. Connor(Merck & Co., Inc., Rahway, NJ, USA (United States)), Frederick R. Taylor(University of Colorado Boulder), David Hewitt(Glasgow Royal Infirmary), Tony W. Ho(Johns Hopkins University), Xiaoyin Fan(Merck & Co., Inc., Rahway, NJ, USA (United States)), Carolyn M. Hustad(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jeanne LaSorda(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ying Zhang(Capital University of Physical Education and Sports), Yang Ge(Shandong Institute of Automation), Lawrence C. Newman(Roosevelt Hospital), Deborah I. Friedman(Texas Neurology)
Cited by 26
Related Papers
Advances in Neuropathic Pain
|Archives of Neurology|2003|1.2k
Sources of variance in 24-hour dietary recall data: implications for nutrition study design and interpretation
|American Journal of Clinical Nutrition|1979|997
MALIGNANT DISEASE IN CHILDHOOD AND DIAGNOSTIC IRRADIATION IN UTERO
|The Lancet|1956|569